COA’s Neurology Division and the NIH Study for Duchenne Muscular Dystrophy
Michael A. Lopez, M.D., Ph.D., has received a nearly $1 million grant from the National Institutes of Health’s National Institute of Neurological Disorders and Stroke to expand the current understanding of the role of a TGF-beta transcription factor in the dysregulation of microRNA in Duchenne muscular dystrophy. The goal is to identify aberrant pathways that can be modulated to mitigate DMD pathophysiology.





